Preferred study design for RSABE [Design Issues]

posted by Prasad Tata – 2013-01-04 16:14 (4923 d 20:39 ago) – Posting: # 9784
Views: 3,928

I am looking at diffeent study designs for the Bioequivalence trials. When applying for scaled bioequivalence which study design is superior and gives control over the 90% CI for a highly variable drug.1) 3-way cross over (TRR, RTR, RRT) or 4-way cross over (RRTT, RTRT etc.)


Any guidance with references or right examples will greatly help me.

Prasad Tata

Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
218 visitors (0 registered, 218 guests [including 24 identified bots]).
Forum time: 13:54 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5